[News] Combination chemotherapy for lung cancer patients

20:41 EDT 27 Jun 2013 | The Lancet

The results of a randomised phase 3 trial have shown that combination therapy with carboplatin and pemetrexed, compared with pemetrexed alone, significantly improves survival in patients with advanced non-small-cell lung cancer (NSCLC) and an Easter...

Original Article: [News] Combination chemotherapy for lung cancer patients

NEXT ARTICLE

More From BioPortfolio on "[News] Combination chemotherapy for lung cancer patients"

Search BioPortfolio:
Loading
Advertisement

Relevant Topics

Top five promising drugs Phase III (February 2014)
Latest News Clinical Trials Research Drugs Reports Corporate
THE FIVE MOST PROMISING DRUGS ENTERING PHASE III TRIALS February 2014 Drug Disease Company Lu-AE58054 Alzheimer’s disease H. Lundbeck / Otsuka Pharmaceutical Patisiran ...

Gilotrif (afatinib)
Latest News Clinical Trials Research Drugs Reports Corporate
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...

Cancer
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs.  Cancer sometimes begins in one part of the body before spre...

Advertisement